European Leukemia Trial Registry
Trial: Eltrombopag

More Details
Title Eltrombopag in MDS and AML with Thrombocytopenia
Scientific Title A Phase I/II Study of Eltrombopag in Thrombocytopenic Subjects with Advanced Myelodysplastic Syndrome (MDS) or secondary Acute Myeloid Leukemia after MDS (sAML/MDS)
Short Title Eltrombopag
Trialgroup Deutsche MDS
Type of Trial multicentric, randomized, double-blind, double-group
Disease Acute myeloid leukemia(AML) Supportive Care
Myelodysplastic Syndrome(MDS) Intermedia II and high risk
Age >= 18 years
Status Closed
Start of Recruitment 01.02.2010
Leader Germing, Prof. Dr., Ulrich

General Contact Person
Giagounidis, PD Dr. med., Aristoteles
Tel: +49 (0)211 4400 2079
Fax: +49 (0)211 4400 55 2079

Study assistance
Lohrbacher, Vera
Tel: +49 (0)203 546 2442

Centre of Trial Universitätsklinikum Düsseldorf
Shortprotocol Shortprotocol
created 07.01.2010 Irene Gleske
changed 13.11.2014 Alexandra Lucaciu
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | |